Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 346.5B | 297.2B | 272.5B | 240.2B |
Cost of revenue | 319.4B | 273.1B | 249.8B | 220.1B |
Gross profit | 27.1B | 24.0B | 22.7B | 20.1B |
Operating expense | ||||
Research & development | 6.3B | 7.3B | 6.2B | 6.7B |
Selling general and admin | 5.6B | 4.9B | 5.2B | 4.7B |
Other operating expenses | — | — | — | — |
Operating income | 15.1B | 11.9B | 11.4B | 8.7B |
Non operating interest income | ||||
Income | 699.8M | 850.2M | 819.5M | 648.6M |
Expense | 2.3B | 1.9B | 2.0B | 2.0B |
Other income expense | — | — | — | — |
Pretax income | 14.8B | 12.7B | 10.2B | 9.1B |
Tax provision | 3.6B | 3.2B | 2.3B | 2.1B |
Net income | 11.2B | 9.5B | 7.9B | 7.1B |
Basic EPS | 1.9 | — | 1.5 | 1.6 |
Diluted EPS | 1.8 | — | 1.5 | 1.5 |
Basic average shares | 2.9B | — | 2.9B | 2.8B |
Diluted average shares | 2.9B | — | 2.9B | 2.9B |
EBITDA | 19.9B | 17.4B | 15.0B | 13.9B |
Net income from continuing op. | 14.8B | 12.7B | 10.2B | 9.1B |
Minority interests | -5.8B | -4.1B | -3.7B | -2.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |